Literature DB >> 3718631

Acute massive digoxin overdose: survival without use of digitalis-specific antibodies.

M Springer, K R Olson, W Feaster.   

Abstract

Acute massive digoxin overdose may result in life-threatening arrhythmias, with reported mortality of up to 20% prior to the introduction of digitalis-specific antibodies. Digitalis-specific Fab antibody fragments remain under experimental protocol and are not widely available. Interpretation of serum digoxin levels and indications for the use of Fab are not clearly established. The authors report a case of massive digoxin overdose in an 18-month-old child with the highest reported digoxin level (48 ng/ml) with which a victim survived without the need for Fab administration. She developed only mild manifestations of digitalis intoxication, and her serum potassium never exceeded 5.2 mEq/l. Her course may be explained by the distribution kinetics of digoxin, which follows a two-compartment model, and the relative resistance of children to digitalis intoxication. This case emphasizes the need for better criteria than the digoxin level for the administration of Fab. The serum potassium concentration, which is usually elevated in acute type digitalis intoxication, may be a better predictor of the need for Fab in acute massive digitalis ingestion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718631     DOI: 10.1016/0735-6757(86)90311-6

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

Review 1.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

Review 2.  Physical assessment and differential diagnosis of the poisoned patient.

Authors:  K R Olson; P R Pentel; M T Kelley
Journal:  Med Toxicol       Date:  1987 Jan-Feb

3.  Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report.

Authors:  Deven Juneja; Omender Singh; Alka Bhasin; Manish Gupta; Sanjay Saxena; Archana Chaturvedi
Journal:  Indian J Crit Care Med       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.